1. Home
  2. ALVR vs FOSL Comparison

ALVR vs FOSL Comparison

Compare ALVR & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • FOSL
  • Stock Information
  • Founded
  • ALVR 2013
  • FOSL 1984
  • Country
  • ALVR United States
  • FOSL United States
  • Employees
  • ALVR N/A
  • FOSL N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • FOSL Consumer Specialties
  • Sector
  • ALVR Health Care
  • FOSL Consumer Discretionary
  • Exchange
  • ALVR Nasdaq
  • FOSL Nasdaq
  • Market Cap
  • ALVR 87.7M
  • FOSL 55.3M
  • IPO Year
  • ALVR 2020
  • FOSL 1993
  • Fundamental
  • Price
  • ALVR $0.94
  • FOSL $1.22
  • Analyst Decision
  • ALVR Sell
  • FOSL
  • Analyst Count
  • ALVR 5
  • FOSL 0
  • Target Price
  • ALVR $1.00
  • FOSL N/A
  • AVG Volume (30 Days)
  • ALVR 155.6K
  • FOSL 196.4K
  • Earning Date
  • ALVR 11-04-2024
  • FOSL 11-07-2024
  • Dividend Yield
  • ALVR N/A
  • FOSL N/A
  • EPS Growth
  • ALVR N/A
  • FOSL N/A
  • EPS
  • ALVR N/A
  • FOSL N/A
  • Revenue
  • ALVR N/A
  • FOSL $1,280,256,000.00
  • Revenue This Year
  • ALVR N/A
  • FOSL N/A
  • Revenue Next Year
  • ALVR N/A
  • FOSL N/A
  • P/E Ratio
  • ALVR N/A
  • FOSL N/A
  • Revenue Growth
  • ALVR N/A
  • FOSL N/A
  • 52 Week Low
  • ALVR $0.58
  • FOSL $0.75
  • 52 Week High
  • ALVR $2.49
  • FOSL $1.83
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 69.10
  • FOSL 50.18
  • Support Level
  • ALVR $0.74
  • FOSL $1.13
  • Resistance Level
  • ALVR $0.91
  • FOSL $1.19
  • Average True Range (ATR)
  • ALVR 0.06
  • FOSL 0.05
  • MACD
  • ALVR 0.01
  • FOSL -0.01
  • Stochastic Oscillator
  • ALVR 94.50
  • FOSL 40.00

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Share on Social Networks: